Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing
Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration
Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52